CN Patent

CN110891561B — 治疗痤疮的方法和组合物

Assigned to Shenzhen Beimei Pharmaceutical Co Ltd · Expires 2025-11-25 · 0y expired

What this patent protects

本申请涉及在患有痤疮的受试者中治疗痤疮的方案、治疗方法和组合物。

USPTO Abstract

本申请涉及在患有痤疮的受试者中治疗痤疮的方案、治疗方法和组合物。

Drugs covered by this patent

Benzamycin (BENZOYL PEROXIDE) · Mayne Pharma

Patent Metadata

Patent number: CN110891561B
Jurisdiction: CN
Classification: —
Expires: 2025-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen Beimei Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.